The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 24955889 |
16 |
Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis. |
Institute Of Chinese Materia Medica |
| 9836620 |
94 |
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. |
Glaxo Wellcome Research And Development |
| 24462665 |
30 |
Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPAR¿ agonists. |
Glaxosmithkline |
| 20527969 |
27 |
Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone. |
Kyorin Pharmaceutical |
| 17964792 |
31 |
Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists. |
Nippon Shinyaku |
| 18280733 |
27 |
Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists. |
Nippon Shinyaku |
| 22133631 |
76 |
Discovery of cyclic amine-substituted benzoic acids as PPARa agonists. |
Kyorin Pharmaceutical |
| 21493073 |
1 |
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. |
Kyoto Pharmaceutical University |
| 20452212 |
26 |
Glycine amides as PPARalpha agonists. |
Bayer-Schering Pharma |
| 20079636 |
78 |
Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators. |
Glaxosmithkline |
| 18947994 |
102 |
The discovery of equipotent PPARalpha/gamma dual activators. |
Glaxosmithkline |
| 18752947 |
7 |
New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies. |
National Institute Of Pharmaceutical Education And Research |
| 18060776 |
100 |
Design, synthesis and evaluation of trifluoromethane sulfonamide derivatives as new potent and selective peroxisome proliferator-activated receptor alpha agonists. |
Glaxosmithkline |
| 17157013 |
74 |
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists. |
Bayer Pharmaceuticals |
| 15293980 |
47 |
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. |
Glaxosmithkline |
| 15163205 |
94 |
(2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents. |
Merck Research Laboratories |
| 12699745 |
49 |
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity. |
Glaxosmithkline |
| 11677135 |
21 |
Identification of a series of PPAR gamma/delta dual agonists via solid-phase parallel synthesis. |
Glaxosmithkline |
| 11354382 |
42 |
Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. |
Glaxosmithkline |
| 10691680 |
72 |
The PPARs: from orphan receptors to drug discovery. |
Glaxo Wellcome Research & Development |
| 10508427 |
42 |
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity. |
Glaxo Wellcome Research & Development |
| 8576907 |
13 |
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. |
Glaxo Wellcome Research And Development |
Search and Browse
